Vaccines for children
Ended Awarded Last action
- Contract number
- 75D30121D10573
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Vaccines for Children 2021 Solicitation · 75D30121R71773 · Posted Jan 21, 2021
- Last date to order 100% complete
- IDV ceiling
- $1,039,367,675.00
- Maximum order
- $1,039,367,675.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention awarded multiple indefinite delivery contracts under the Vaccines for Children 2021 program to support pediatric immunization efforts. The contracts hold a potential value of $1.039 billion and were awarded to Glaxosmithkline, LLC for the period of April 1, 2021 through March 31, 2022. The contracts will provide 20 standard pediatric vaccines to the CDC's Immunization Awardees for distribution through the Vaccines for Children program and Section 317(j) of the Public Health Service Act. Estimated quantities range from a minimum of 100 doses to a maximum of 13 million doses per vaccine. Performance will occur across the 50 U.S. states and territories.
The original solicitation sought the vaccines to maintain at least a 12-month shelf life and be manufactured under a current FDA license. Questions were due by January 28, 2021 and offers by February 4, 2021, with award occurring on August 6, 2021. There was no set-aside designation. The vaccines aim to support routine immunization efforts through the CDC's programs, helping to provide pediatric immunizations nationwide.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | -$1,214 | |
| Funding Only Action | $66,122,986 | |
| Funding Only Action | $278,645,190 | |
| Funding Only Action | $51,963,554 | |
| Funding Only Action | $259,904,220 | |
| Funding Only Action | $641,228 | |
| Original award | $221,790,814 |
Quick answers
Who was awarded contract 75D30121D10573?
75D30121D10573 was awarded to Glaxosmithkline, LLC by CDC Pittsburgh (Centers for Disease Control and Prevention) on April 1, 2021.
How much is contract 75D30121D10573 worth?
75D30121D10573's own ceiling is $1,039,367,675. A single order can be worth up to $1,039,367,675.
Who can order from contract 75D30121D10573?
75D30121D10573 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75D30121D10573 part of a contract vehicle?
Yes. 75D30121D10573 is part of Vaccines for Children 2021.
Was contract 75D30121D10573 competed?
The extent of competition for 75D30121D10573 was full and open competition. The government received 5 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV